FIELD: medicine.
SUBSTANCE: fragments of genes of glutathione-S-transferase GSTM1 and methionine-synthase-reductase MTRR are amplified on DNA isolated from lymphocytes, and in case of determination of GSTM1 del/del genotype in combination with MTRR 66G/G or MTRR 66A/G genotype, conclusion about presence in woman of genetic predisposition to fast growth of myomatous nodes within 5 years from the moment of their appearance is made.
EFFECT: method extends arsenal of prognostic means of detecting fast growth of myomatous nodes, which makes it possible to carry out complex of initial or secondary preventive measures in due time.
2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF UTERINE FIBROID | 2017 |
|
RU2650990C1 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF MYOMATOUS NODES OF LARGE SIZES IN PATIENTS WITH MYOMA | 2016 |
|
RU2616246C1 |
| METHOD FOR PREDICTING UTERINE LEIOMYOMA SIZE INCREASE | 2019 |
|
RU2704817C1 |
| METHOD FOR PREDICTING UTERINE LEIOMYOMA SIZE INCREASE | 2019 |
|
RU2704819C1 |
| METHOD FOR PREDICTING THE PROBABILITY OF DEVELOPMENT OF PROLIFERATING UTERUS MYOMA | 2018 |
|
RU2676035C1 |
| METHOD FOR PREDICTION OF RISK OF RECURRENCE OF SYMPTOMATIC UTERINE MYOMA AFTER SELECTIVE EMBOLIZATION OF UTERINE ARTERIES | 2021 |
|
RU2766809C1 |
| METHOD OF PREDICTING AREA OF MYOMATOUS KNOTS IN CASE OF UTERUS MYOMA | 2010 |
|
RU2433402C1 |
| METHOD FOR DIAGNOSING PROLIFERATIVE ACTIVITY OF UTERINE LEIOMYOMA CELLS | 2019 |
|
RU2700003C1 |
| METHOD FOR PREDICTION OF RISK OF MULTINODULAR LESIONS ACCOMPANYING UTERINE LEIOMYOMA | 2011 |
|
RU2445625C1 |
| METHOD FOR SELECTING UTERINE FIBROID MEDICINE THERAPY AND COMBINATION THEREOF WITH ADENOMYOSIS IN FEMALES | 2019 |
|
RU2718267C1 |
